Daejeon Technopark and NNFC lead the convergence of semiconductor and bio industries. We empower local SMEs by commercializing advanced technologies through strategic consortiums. We aim to establish Daejeon as a global hub for sustainable semiconductor-bio technological convergence.

The 'Bio-CMOS Platform' is a core technology for semiconductor-bio convergence. It delivers custom solutions for medical fields, specializing in ROIC component design and verification. By integrating electronic circuits into organoids, it accelerates next-gen bio market commercialization.